Gastrointestinal Stromal Tumor (GIST) Drug Market Report

Global and China Gastrointestinal Stromal Tumor (GIST) Drug Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 09, 2022
  • PAGES：192
  • REPORT CODE：GMM1448225
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Gastrointestinal Stromal Tumor (GIST) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astex Pharmaceuticals, Inc

    • Array BioPharma Inc

    • Horizon Pharma Plc

    • Kolltan Pharmaceuticals, Inc

    • Boston Biomedical, Inc

    • Jiangsu Hengrui Medicine Co, Ltd

    • Deciphera Pharmaceuticals, LLC

    • Immunicum AB

    • Nerviano Medical Sciences Srl

    • Arog Pharmaceuticals, Inc

    • Novartis AG

    • Calithera Biosciences, Inc

    • Chipscreen Biosciences Ltd

    • Blueprint Medicines Corporation

    • Natco Pharma Limited

    • Ariad Pharmaceuticals, Inc

    • Omeros Corporation

    • F Hoffmann-La Roche Ltd

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Amcasertib

    • Anagrelide hydrochloride CR

    • APG-1351

    • Binimetinib

    • Others

    Application:

    • Clinic

    • Hospital

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Overview

      • 1.1.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Scope and Market Segments

      • 1.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Industry Characteristics

      • 1.1.3 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Amcasertib

      • 1.2.2 Anagrelide hydrochloride CR

      • 1.2.3 APG-1351

      • 1.2.4 Binimetinib

      • 1.2.5 Others

    • 1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Clinic

      • 1.3.2 Hospital

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Industry PEST Analysis

    • 2.3 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Gastrointestinal Stromal Tumor (GIST) Drug Industry

    Chapter 3 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market, by Manufacturer

    • 3.1 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Top 3 Players

    Chapter 4 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market, by Type (2017-2028)

    • 4.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend, by Type

    • 4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trend, by Type (2017-2028)

    • 4.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Gastrointestinal Stromal Tumor (GIST) Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis

    • 7.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market, by Type

    • 7.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market, by Application

    • 7.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis

    • 8.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market, by Type

    • 8.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market, by Application

    • 8.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis

    • 9.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Market, by Type

    • 9.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Market, by Application

    • 9.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Gastrointestinal Stromal Tumor (GIST) Drug Company Profiles

      • 11.1 Astex Pharmaceuticals, Inc

        • 11.1.1 Astex Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.1.3 Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Array BioPharma Inc

        • 11.2.1 Array BioPharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.2.3 Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Horizon Pharma Plc

        • 11.3.1 Horizon Pharma Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.3.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Kolltan Pharmaceuticals, Inc

        • 11.4.1 Kolltan Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.4.3 Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Boston Biomedical, Inc

        • 11.5.1 Boston Biomedical, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.5.3 Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Jiangsu Hengrui Medicine Co, Ltd

        • 11.6.1 Jiangsu Hengrui Medicine Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.6.3 Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Deciphera Pharmaceuticals, LLC

        • 11.7.1 Deciphera Pharmaceuticals, LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.7.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Immunicum AB

        • 11.8.1 Immunicum AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.8.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Nerviano Medical Sciences Srl

        • 11.9.1 Nerviano Medical Sciences Srl Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.9.3 Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Arog Pharmaceuticals, Inc

        • 11.10.1 Arog Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.10.3 Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Novartis AG

        • 11.11.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.11.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Calithera Biosciences, Inc

        • 11.12.1 Calithera Biosciences, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.12.3 Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Chipscreen Biosciences Ltd

        • 11.13.1 Chipscreen Biosciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.13.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Blueprint Medicines Corporation

        • 11.14.1 Blueprint Medicines Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.14.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Natco Pharma Limited

        • 11.15.1 Natco Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Ariad Pharmaceuticals, Inc

        • 11.16.1 Ariad Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.16.3 Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Omeros Corporation

        • 11.17.1 Omeros Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.17.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 F Hoffmann-La Roche Ltd

        • 11.18.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Profiles, Application and Specification

        • 11.18.3 F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Gastrointestinal Stromal Tumor (GIST) Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Gastrointestinal Stromal Tumor (GIST) Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Value and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Amcasertib (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Anagrelide hydrochloride CR (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of APG-1351 (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Binimetinib (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Gastrointestinal Stromal Tumor (GIST) Drug Market Share, by Manufacturer in 2022

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trend, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Type (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Price Trend, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales Value and Growth Rate (2017-2028)

    • Table Astex Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astex Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Astex Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Array BioPharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Array BioPharma Inc Product Profiles, Application and Specification

    • Table Array BioPharma Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Pharma Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Pharma Plc Product Profiles, Application and Specification

    • Table Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kolltan Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kolltan Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Kolltan Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boston Biomedical, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boston Biomedical, Inc Product Profiles, Application and Specification

    • Table Boston Biomedical, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Jiangsu Hengrui Medicine Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jiangsu Hengrui Medicine Co, Ltd Product Profiles, Application and Specification

    • Table Jiangsu Hengrui Medicine Co, Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Deciphera Pharmaceuticals, LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Deciphera Pharmaceuticals, LLC Product Profiles, Application and Specification

    • Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Immunicum AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Immunicum AB Product Profiles, Application and Specification

    • Table Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nerviano Medical Sciences Srl Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nerviano Medical Sciences Srl Product Profiles, Application and Specification

    • Table Nerviano Medical Sciences Srl Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arog Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arog Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Arog Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Calithera Biosciences, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Calithera Biosciences, Inc Product Profiles, Application and Specification

    • Table Calithera Biosciences, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chipscreen Biosciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chipscreen Biosciences Ltd Product Profiles, Application and Specification

    • Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Blueprint Medicines Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Blueprint Medicines Corporation Product Profiles, Application and Specification

    • Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Natco Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Natco Pharma Limited Product Profiles, Application and Specification

    • Table Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ariad Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ariad Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Ariad Pharmaceuticals, Inc Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Omeros Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Omeros Corporation Product Profiles, Application and Specification

    • Table Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US